Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Baxter
McKesson
McKinsey
Chubb
Daiichi Sankyo

Generated: September 19, 2019

DrugPatentWatch Database Preview

Patent: 10,105,356

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 10,105,356
Title:Aerosol pirfenidone and pyridone analog compounds and uses thereof
Abstract: Disclosed herein are formulations of pirfenidone or pyridone analog compounds for aerosolization and use of such formulations for aerosol administration of pirfenidone or pyridone analog compounds for the prevention or treatment of various fibrotic and inflammatory diseases, including disease associated with the lung, heart, kidney, liver, eye and central nervous system. In some embodiments, pirfenidone or pyridone analog compound formulations and delivery options described herein allow for efficacious local delivery of pirfenidone or pyridone analog compound. Compositions include all formulations, kits, and device combinations described herein. Methods include inhalation procedures, indications and manufacturing processes for production and use of the compositions described.
Inventor(s): Surber; Mark William (San Diego, CA)
Assignee: Avalyn Pharma Inc. (Seattle, WA)
Application Number:13/950,110
Patent Claims:see list of patent claims

Details for Patent 10,105,356

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Biogen AVONEX interferon beta-1a VIAL 103628 001 1996-05-17 ➤ Sign Up Avalyn Pharma Inc. (Seattle, WA) 2031-01-31 RX search
Serono Inc REBIF interferon beta-1a SYRINGE 103780 001 2002-03-07 ➤ Sign Up Avalyn Pharma Inc. (Seattle, WA) 2031-01-31 RX search
Serono Inc REBIF interferon beta-1a SYRINGE 103780 002 2002-03-07 ➤ Sign Up Avalyn Pharma Inc. (Seattle, WA) 2031-01-31 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Federal Trade Commission
McKesson
Express Scripts
Boehringer Ingelheim
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.